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Leishmaniasis is endemic in 88 countries and 350 million
people are at risk for acquiring one or the other form of leish-
maniasis with an overall prevalence of 12 million worldwide.
The visceral type, visceral leishmaniasis (VL) or kala-azar
was known to be endemic in Southern Terai (plain region) of
Nepal since 1953. Approximately 5.5 million inhabitants are
estimated to be at risk of VL in Nepal at present.
We conducted a study to investigate the health seek-
ing behavior and out-of-pocket expenditure for health in
patients with VL in Nepal. A sample of VL patients was inter-
viewed at B.P. Koirala Institute of Health Sciences (BPKIHS),
a hospital located within the endemic region for Kala-azar
in Nepal.
Between September and November 2004 one hundred
sixty patients were conﬁrmed with a diagnosis of Kala-azar
at BPKIHS. Out of these, 60 [37.5 per cent of 160] patients
were enrolled for the study; among them 52 per cent were
males. Age of the study population ranged between 18 to 75
yrs, with mean age of 32.3 yrs (SD± 15.1).
Almost half of the patients delayed seeking care for VL
for more than 100 days. In addition, the factors playing a
signiﬁcant role in making delayed health seeking were found
as gender, perception of disease and the stigma attached.
The study got evidence that the severity of the disease and
its immediate economic and social impacts determines the
decision making regarding the health seeking behavior more
than knowledge about the disease.
Almost all of the patients (95 per cent) had visited tra-
ditional healers followed by private health care providers
[46.7 per cent] for treatment of illness. Their visit to gov-
ernment health care providers and referral center is either
fourth or ﬁfth which explains delays in the adequate man-
agement of the patient.
The out of pocket expenditure of the patient is maximum
in the treatment of kala-azar. The mean total expenditure
in VL is 105 US$. An average of 100 days of working days
(maximum 210 days and minimum 14 days) was lost due to
the disease.
The ﬁndings of the study reﬂects on the advocacy, sensi-
tization and develop skill of protection and control measures
to the individuals. The advocacy/awareness intervention is
most essential part to reduce the kala-azar morbidity and
mortality.
Some major interventions are recommended in this study
to reduce morbidity and mortality of VL is given below.
Advocacy, orientation and health education should be
provided regarding Kala-azar disease, its transmission, and
preventive & control measures to family level, child and
youth group, mothers groups and school students as well
as community level. It should be in multi disciplinary
approach. Educational programs focused on reducing stigma
and increasing control over the resources of females and
decision making process in health seeking behaviors of VL
and to be conducted in formal and informal settings.
As there is a strong stigma regarding the traditional
healers in the population, the use of traditional healers
for health education and development of awareness of the
disease can be implicated. Training and orientation to tra-
ditional healers on modern treatment systems should be
provided to increase the utilization of modern health facil-
ity.
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Background: Leishmaniasis, caused by an intracellular
protozoan parasite, Leishmania major which is transmit-
ted through the bite of sand ﬂies. The disease is prevalent
in many parts of the world. TSA is the immuno-dominant
antigen of Leishmania major which is considered as the
most promising molecule for a recombinant or DNA vaccine
against leishmaniasis.
Materials and Methods: In the present study, we evalu-
ated TSA - encoded DNA vaccine against Leishmania major in
BALB/c mice. The ﬁrst was done the genomic DNA extraction
and then, done PCR ampliﬁcation and recombinant plasmid
construction and tranfection of recombinant pcTSA into the
eukaryotic cells and then done SDS-PAGE and Western blot
analysis. The mice were grouped to be based on administra-
tion content as follows: 1-PBS (as control group), 2-pcDNA3
(as control group), 3-pcTSA (as vaccinated group) (100g of
pcTSA).
The mice were immunized via intramuscular (i.m.)into
both quadricepses with 100L of administration con-
tent according to their grouping. Three inoculations were
employed at two weeks interval. Three weeks after the
last immunization, mice of each groups (vaccinated and
unvaccinated mice) were challenged at the base of tail
by the intradermal (i.d.) route with 2× 106 Leishmania
major promastigotes (Strain MRHO/IR/75/ER). The measur-
ing of the diameter of lesion at the site of inoculation
was monitored weekly by a Vernier caliper thereafter. Also
the measuring of the weight was monitored weekly by a
scale. All groups of mice were evaluated for lesion devel-
opment and weight increasing for up to 7 weeks after
challenge with Leishmania major. Then, animals were sacri-
ﬁced and was done determination of parasite burden in their
spleen.
The statistical comparisons between experimental
groups were carried out with an analysis of variance (ANOVA)
